HETRICK: How far would and should you go to forgive?
Moral questions abound, from Poland to Penn State.
Moral questions abound, from Poland to Penn State.
Charitable giving grew 4 percent nationally in 2011, but the increase was less than 1 percent after adjusting for inflation, according to a report released Tuesday by the Giving USA Foundation and The Center on Philanthropy at Indiana University.
WellPoint Inc. lowered its 2012 profit forecast 23 cents per share, or nearly 3 percent, due to a $90 million settlement in a class-action lawsuit. Lawyers for former policyholders of Anthem Insurance Cos. Inc., the predecessor of Indianapolis-based WellPoint, disclosed the settlement Friday afternoon. Pending approval by a federal judge, the settlement would cover the claims of more than 700,000 former policyholders, whose stakes in Anthem were undervalued, according to the lawsuit, before the company’s 2001 conversion from a mutual insurance company into a publicly traded one. Because of the settlement, Anthem now expects to earn a 2012 profit of $7.57 per share, down from a previous estimate of $7.80 per share.
Hancock Regional Hospital is moving to acquire nearly 50 acres in McCordsville, even though it has no specific expansion plan. According to the Greenfield Daily Reporter, the hospital’s board of trustees approved spending up to $1.2 million for the 48.5-acre parcel in the Villages of Brookside development. Hancock Regional, based in Greenfield, has made a tentative offer for the land to its current owner, Cincinnati-based Fifth Third Bank. The offer hinges on an environmental assessment that is still under way. If the bid is accepted, said Rob Matt, Hancock Regional’s vice president of development, the land could become the location for additional medical office space, another wellness center or another surgery center. But in the short term, the hospital likely would lease the land for farming. “We’re not exactly sure what the future holds, but we think McCordsville is a great location for potential future expansion of a variety of health services,” Matt said. The land was part of a 300-acre development started in 2005. But the sections of the project that were marked off for business and apartments have been slow to develop because of the housing slump, financial crisis and recession.
Eli Lilly and Co. invested $20 million in a Chinese pharmaceutical company in an effort to build a portfolio of branded generic medicines in the fast-growing Asian market. Novast Laboratories Ltd., based north of Shanghai, received a $10 million initial investment from Indianapolis-based Lilly five years ago. The new money, announced June 12, will fund an expansion of Novast’s manufacturing capabilities. Lilly is working with Novast to develop a catalog of generic versions of medicines not created by Lilly that will be branded with the Lilly name. Down the road, Novast also may take on manufacturing responsibilities for new drugs Lilly launches in China and other Asian countries. Since 2009, Lilly has rapidly ramped up sales and research functions in China, and now employs more than 3,000 people there. In June, Lilly announced the opening of a research and development center in Shanghai focused exclusively on diabetes. It employs 150. Lilly's sales in China increased 31 percent last year, to nearly $420 million, according to company officials.
An Indian-born physician fired by St. Vincent Health is suing the hospital network in federal court on charges of discrimination and harassment. Seema Nayak filed her suit June 13 and is seeking past and future pay in addition to other damages for the hospital’s “malicious and/or reckless conduct.” St. Vincent officials did not return messages seeking comment on the suit. Nayak’s suit follows a complaint she filed in October 2010 with the U.S. Equal Employment Opportunity Commission, which granted her the right to sue. Her employment contract was not renewed by the hospital in June 2010. She began her first-year residency program at St. Vincent in July 2007 in the obstetrics and gynecology department. Though Nayak exceeded performance standards during her first- and second-year residencies, according to the suit, she became the target of discrimination from other residents due to her accent and Indian origin. Later, her suit alleges, St. Vincent also pressured her to return to work quickly after taking maternity leave and then retaliated against her by giving her an especially difficult residency rotation.
I’ve been taking my kids and their pals to Conner Prairie for 15 years. But the most recent visit was the first time they wanted to spend the whole time in Prairietown.
Median household income fell 13.6 percent—the second-largest decrease in the nation.
Tim Durham’s attorney is hellbent on preventing prosecutors from fixating on the things that made the Indianapolis financier a staple of TV news and gossip columns—his fancy cars, waterfront mansion and other trappings of a lavish lifestyle. Durham’s trial is set to begin on Friday.
Dave Menzer, director of the Sierra Club’s new “Beyond Coal” campaign in Indiana, aims to spark discussion about the health and environmental costs of the state’s bituminous bounty that for years has brought relatively cheap electric rates.
After three years of shrinking budgets, Indianapolis Museum of Art leaders are ready to leave the lean times behind. The IMA’s endowment, which has covered close to 70 percent of operating expenses, is on the rebound and reached $324 million at the end of last year.
Most analysts agree with Eli Lilly and Co.’s prediction that, after tough years from 2012 to 2014, the drugmaker will start growing sales and profits again. But in a new report, BMO Capital Markets predicts Lilly will get stuck at a reduced level of revenue and profit in 2014 and stay there for years. “We […]
Most analysts agree with Eli Lilly and Co.’s prediction that, after tough years from 2012 to 2014, the drugmaker will begin growing sales and profits again. But in a new report, BMO Capital Markets predicts Lilly will get stuck at a reduced level of revenue and profit in 2014 and stay there for years.
The two main retail centers in a northeast-side development area will be at 100-percent occupancy when Uncle Bill’s Pet Express opens in a small space at Binford Boulevard and 71st Street. Binford Area Growth and Revitalization, a super-neighborhood association better known as BRAG, began striving for this milestone in 2005.
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
Louisville-based Neace Lukens has acquired Indianapolis-based Benefit Concepts Inc. to expand its benefits-consulting business in Indiana. Benefit Concepts' six employees will move into the Neace Lukens office at 6510 N. Shadeland Ave., reporting to Eric Chelovitz, Neace Lukens managing director of Indianapolis. Even before the acquisition, Neace Lukens had about 30 employees in Indiana. The firm was acquired in September by Florida-based AssuredPartners Inc. Numerous small-benefits consultants have sold their businesses in recent years to larger companies, first as employer efforts to change workers’ health habits hiked demands on brokers and now as the 2010 health reform law significantly curtails the health insurance commission system on which many health care brokers have survived for decades.
Purdue University's trustees approved plans Friday for a new campus medical clinic that administrators expect eventually will reduce the school's $151 million in annual health care costs for employees and their families. The clinic is scheduled to open this fall on the West Lafayette campus under a three-year contract paying about $14 million to a private provider, the Journal & Courier of Lafayette reported. The center will be available to all active employees and dependents covered by a Purdue medical plan. Primary and acute care will be offered, with patients not being charged for wellness coaching, chronic condition management and lab work for blood and other tests. Purdue's contract with clinic operator CHS of Reston, Va., is valued at $13.2 million to $14.7 million. The university's contribution to health care costs increased 6 percent, to $10,580 per employee, for 2012.
Bad news from a competitor has darkened the cloud over one of Eli Lilly and Co.’s most anticipated experimental drugs, evacetrapib, which has shown promise at boosting good cholesterol in heart patients. Swiss drugmaker Roche Holding AG said May 6 it has halted testing of its dalcetrapib, which the company had hoped would become a blockbuster, according to Bloomberg News. That move comes five years after New York-based Pfizer Inc. dumped a similar drug called torcetrapib due to safety issues. Lilly and New Jersey-based Merck & Co. Inc. still are developing their drugs in a class known as CETP inhibitors. Drugmakers have hoped that such drugs could replace statins as the next big medicine for heart patients. Statins, such as Pfizer’s Lipitor, were huge blockbusters, but most of them have now seen their patents expire. A Lilly spokeswoman told Bloomberg the Indianapolis-based company is committed to evacetrapib and plans to start a late-stage study in the second half of this year. A Phase 2 trial of the drug showed that it increases good cholesterol up to 129 percent and reduces bad cholesterol as much as 36 percent.
City leaders once envisioned the Canal Walk as a bustling pathway lined with restaurants and shops, but residential and office buildings have sprouted instead on most of the parcels along the meandering 1-1/2-mile stretch–making it more of a local amenity than a visitor attraction.
Last in a month-long series of reviews of eateries in and around City Market. This week: something from here and there.
Katherine Peck has been named executive associate dean for administration, operations and finance at the Indiana University School of Medicine. Peck was associate dean of financial services at the University of Florida College of Medicine. Before joining the University of Florida in 2000, Peck was the controller for several private companies in a variety of industries including biotechnology, manufacturing and environmental waste management. Peck holds a bachelor’s degree from Oberlin College and an MBA from Yale University School of Management.
Dr. Glenn Dobbs will provide obstetric services at Franciscan St. Francis Health’s Mooresville hospital. The arrival of Dobbs and the physician group he belongs to, Southside OB-GYN, helps Franciscan avoid a gap in obstetrics in Mooresville. The physician group that provides those services, Southwest Women’s Health, is scheduled to end its relationship with Franciscan-Mooresville in May. Dobbs, who specializes in high-risk obstetrics, did his medical training at Western University of Health Sciences in California.
Purdue University plans to start construction this summer on two academic buildings in a $79 million project for its newly designated Life and Health Sciences Park, according to the Journal & Courier of Lafayette. The $38 million Lyles-Porter Hall will house health programs, including Purdue's speech and hearing sciences department and the West Lafayette programs of the Indiana University School of Medicine. Purdue also is planning a $25 million Drug Discovery Building that will bring together pharmaceutical researchers from throughout the school. Plans are for the buildings and a new 850-space parking garage to be completed in 2014.
More than 70 workers will lose their jobs at Integra Specialty Hospital in Muncie when it closes in June. Hospital officials notified the Indiana Department of Workforce Development on Thursday that the 32-bed long-term-care facility will shut down on June 17. Renaissance Specialty Hospital of Central Indiana Operations Co. LLC, which operates Integra, did not provide a reason for the closing. The company said it expects that some of the 72 employees will be offered the opportunity to transfer to other long-term-care facilities.
Eli Lilly and Co. could receive up to $100 million from Washington, D.C.,-based Vanda Pharmaceuticals Inc., which licensed an alcohol-dependence drug from the Indianapolis drugmaker last week. The experimental drug, called LY686017, has been shown to reduce alcohol cravings and consumption in alcoholics. If it reaches the market, the drug would compete with Emend, a similar NK-1R antagonist made by New Jersey-based Merck & Co. Inc.
The government-contracting arm of WellPoint Inc. won a renewal of its contract, worth more than $111 million, to support the desktop program used by customer service representatives at the Centers for Medicare & Medicaid Services for the next five years. WellPoint’s National Government Services unit has held the contract since the program’s inception. The program helped Medicare’s call center field 26 million calls last year. NGS, which employs 2,000, also processed 170 million Medicare claims and administered benefits of $75.6 billion from the Medicare Trust Fund in 2011.
An animal rights group wants the federal government to fine a research institute owned by Indiana University Health for what it calls negligence toward animals, according to the Associated Press. The group Stop Animal Exploitation Now says IU Health's Methodist Research Institute had seven violations, including killing one dog and putting another dog in severe pain. According to a March report from the U.S. Department of Agriculture, a dog was fed before surgery, which violated proper protocol. The dog’s heart stopped, and it died. IU Health officials said in a statement that the use of animals in research has contributed significantly to advancements in health care.